Skip to main content

Mosaic ImmunoEngineering Inc.

corporate_fare Company Profile

Mosaic ImmunoEngineering Inc.

CPMV·OTC·Life Sciences·CIK 0000836564

Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company focused on advancing and commercializing immunotherapies for cancer treatment. The company has historically developed early-stage product candidates and is now pursuing new product candidates and platforms to build a product pipeline, leveraging its understanding of immunotherapies. Its business strategy involves using industry experience, immunotherapy knowledge, and development expertise to identify, develop, and commercialize product candidates that address unmet medical needs in cancer treatment and have significant market potential. The company has a management team and scientific and business advisors, including experts in immunotherapy, with industry and regulatory experience to lead product development and commercialization. Mosaic ImmunoEngineering Inc. is focused on identifying and licensing or acquiring new product candidates. As part of this strategy, on April 26, 2024, the company entered into a binding term sheet with Oncotelic Therapeutics, Inc. to acquire certain rights to Oncotelic's clinical-stage necroptosis cancer therapies associated with its vascular disruptive agents and related regulatory and clinical packages. It also intends to acquire non-exclusive access to Oncotelic's proprietary Artificial Intelligence technologies for identifying immunotherapy combinations. This acquisition is in exchange for shares of Mosaic ImmunoEngineering Inc. common stock valued at $15.0 million upon execution of the definitive agreement, or a combination of common stock and preferred stock. Additionally, Oncotelic can earn up to an additional $15.0 million in shares of common stock, valued at the time of issuance, if specific milestones are met.

Mosaic ImmunoEngineering Inc. (OTC:CPMV) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 4 items for CPMV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for CPMV spans 10-Q, 10-K.

Recent high-impact activity:

  • Mosaic Q3 10-Q: Cash Down to $151, Going Concern Stands, Liabilities Near $8M
  • Mosaic ImmunoEngineering Reports $26 Cash, Reiterates Going Concern
  • Mosaic ImmunoEngineering Reports $72 Cash, Reiterates Going Concern, and Confirms Failed Strategic Acquisition
  • Mosaic ImmunoEngineering Faces Substantial Doubt on Going Concern, Reports Critical Liquidity Issues and Loss of Key License

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$687.85K
Diluted EPS
-$0.10
Op. Cash Flow
-$111.4K
Operating Income
-$616.12K
Cash & Equivalents
$3.62K
Debt / Equity
0.00×
Shares Outstanding
7.24M sh
Source: 10-K · filed 2026-04-15 · accession 0001683168-26-002977

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 521 shares in CPMV as of the October 30, 2026 settlement, a 330.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 17, 2026, 100.0% of CPMV volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)521 shares as of October 30, 2026
Change vs prior period▲ 330.6%
Days to cover1.00 at avg daily volume of 3,288
Daily short volume (FINRA facilities)100.0% of 108 shares on November 17, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$0.0851 +11.97% today
52-week range · as of 2026-11-20 $0.054 – $1.13
Market cap
$616.31K
Volume
12K (5.9× avg)
3-mo avg 2K
Live data · 2026-11-22 03:30 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CPMV - Latest Insights

CPMV
Nov 20, 2026, 12:55 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.076
Real-time Price: $0.0851 info
Change: +$0.0091 (+12%) info
Market Cap: $616.306K info
CPMV
Aug 14, 2026, 12:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.061
Real-time Price: $0.0851 info
Change: +$0.0241 (+40%) info
Market Cap: $616.306K info
CPMV
May 20, 2026, 11:44 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.6948
Real-time Price: $0.0851 info
Change: -$0.6097 (-88%) info
Market Cap: $616.306K info
CPMV
Apr 15, 2026, 1:55 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.69496
Real-time Price: $0.0851 info
Change: -$0.60986 (-88%) info
Market Cap: $616.306K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets